Chemoinformaics analysis of 5-METHYLHEXYL 2-METHYLBUTANOATE
| Molecular Weight | 200.322 | nRot | 7 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 1 |
| Exact Molecular Weight | 200.178 | nRing | 0 |
| Solubility: LogS | -4.18 | nHRing | 0 |
| Solubility: LogP | 4.249 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 37.647 |
| nHD | 0 | BPOL | 26.681 |
| QED | 0.465 |
| Synth | 2.43 |
| Natural Product Likeliness | 0.703 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.296 |
| MDCK | 0.000024 |
| BBB | 0.792 |
| PPB | 0.799519 |
| VDSS | 1.083 |
| FU | 0.153335 |
| CYP1A2-inh | 0.957 |
| CYP1A2-sub | 0.529 |
| CYP2c19-inh | 0.763 |
| CYP2c19-sub | 0.769 |
| CYP2c9-inh | 0.736 |
| CYP2c9-sub | 0.527 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.106 |
| CYP3a4-inh | 0.17 |
| CYP3a4-sub | 0.294 |
| CL | 10.61 |
| T12 | 0.28 |
| hERG | 0.043 |
| Ames | 0.006 |
| ROA | 0.063 |
| SkinSen | 0.696 |
| Carcinogencity | 0.124 |
| EI | 0.979 |
| Respiratory | 0.513 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.68345 |